Human TRAIL/TNFSF10 Quantikine ELISA Kit

Name Human TRAIL/TNFSF10 Quantikine ELISA Kit
Supplier R&D Systems
Catalog DTRL00
Category ELISA Kit
Prices $509.00
Sizes 1 kit
Assay Type Solid Phase Sandwich ELISA
Sample Type Cell Culture Supernates (50 uL), Cell Lysates (50 uL), Serum (50 uL), EDTA Plasma (50 uL), Heparin Plasma (50 uL), Saliva (25 uL)
Sensitivity 7.87 pg/mL
Range 15.6 - 1,000 pg/mL (Cell Culture Supernates, Cell Lysates, Serum, EDTA Plasma, Heparin Plasma, Saliva)
Format 96-well strip plate
Applications ELISA
Species Reactivities Human
Description The Quantikine Human TRAIL Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human TRAIL in cell culture supernates, serum, plasma, cell lysates, and saliva
Gene TNFSF10
Supplier Page Shop

Product images


Product References

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid - Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid

Remuzgo-Martinez S, Genre F, Lopez-Mejias R, Ubilla B, Mijares V, Pina T, Corrales A, Blanco R, Martin J, Llorca J, Gonzalez-Gay MA. Sci Rep. 2016 Jul 12;6:29713.

Clonal evolution in patients with chronic lymphocytic leukaemia developing - Clonal evolution in patients with chronic lymphocytic leukaemia developing

Burger JA, Landau DA, Taylor-Weiner A, Bozic I, Zhang H, Sarosiek K, Wang L, Stewart C, Fan J, Hoellenriegel J, Sivina M, Dubuc AM, Fraser C, Han Y, Li S, Livak KJ, Zou L, Wan Y, Konoplev S, Sougnez C, Brown JR, Abruzzo LV, Carter SL, Keating MJ, Davids MS, Wierda WG, Cibulskis K, Zenz T, Werner L, Dal Cin P, Kharchencko P, Neuberg D, Kantarjian H, Lander E, Gabriel S, O'Brien S, Letai A, Weitz DA, Nowak MA, Getz G, Wu CJ. Nat Commun. 2016 May 20;7:11589.

TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders - TRAIL Is Decreased Before 20 Weeks Gestation in Women with Hypertensive Disorders

Zhou C, Long Y, Yang H, Zhu C, Ma Q, Zhang Y. PLoS One. 2015 Jun 1;10(6):e0128425.

TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 - TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1

Mohr A, Yu R, Zwacka RM. BMC Cancer. 2015 Jul 3;15:494.

Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA - Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA

Kang S, Kang D, Bakhtiar Ul Islam SM, Je S, Kim JH, Song JJ. Cell Signal. 2015 Jun;27(6):1214-24.

Clinically applicable human adipose tissue-derived mesenchymal stem cells - Clinically applicable human adipose tissue-derived mesenchymal stem cells

Choi SA, Lee YE, Kwak PA, Lee JY, Kim SS, Lee SJ, Phi JH, Wang KC, Song J, Song SH, Joo KM, Kim SK. Cancer Gene Ther. 2015 Jun;22(6):302-11.

A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma - A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma

Ray A, Tian Z, Das DS, Coffman RL, Richardson P, Chauhan D, Anderson KC. Leukemia. 2014 Aug;28(8):1716-24.

Systemic anticancer neural stem cells in combination with a cardiac glycoside for - Systemic anticancer neural stem cells in combination with a cardiac glycoside for

Teng J, Hejazi S, Badr CE, Tannous BA. Stem Cells. 2014 Aug;32(8):2021-32.

Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic - Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic

Zhang Y, Patel B, Dey A, Ghorani E, Rai L, Elham M, Castleton AZ, Fielding AK. J Immunol. 2012 Feb 1;188(3):1002-10.

Potential role of soluble TRAIL in epithelial injury in children with severe RSV - Potential role of soluble TRAIL in epithelial injury in children with severe RSV

Bem RA, Bos AP, Wosten-van Asperen RM, Bruijn M, Lutter R, Sprick MR, van Woensel JB. Am J Respir Cell Mol Biol. 2010 Jun;42(6):697-705.